News Focus
News Focus
Followers 95
Posts 1225
Boards Moderated 0
Alias Born 09/10/2017

Re: hyperopia post# 549367

Friday, 12/16/2022 11:58:54 AM

Friday, December 16, 2022 11:58:54 AM

Post# of 822561
And just to clarify, I’m not suggesting that a buyout is the reason for Northwest Bio’s absence from the Glioblastoma Drug Development Summit, but merely pointing out that I would think that the first company to release successful results in a Glioblastoma trial (in over 400!) would want to share their successful, unique immunotherapy approach with their peers, perhaps network and seek funding opportunities with potential collaboration partners at a conference that is dedicated to developing treatments for Glioblastoma, and it’s a conference they’ve always attended.

It’s not until March, so there’s still time, but in previous years, Dr. Bosch and Dr. Liau were scheduled to speak months in advance. This seems to be a company that’s still in a quiet period, for whatever reason.
(and yes, it may be that they already have a collaboration partner(s) selected)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News